BAAR, CH / / January 19, 2026 / PolyPeptide Group AG (SIX:PPGN), a specialized global CDMO for peptide-based active pharmaceutical ingredients, today announced the successful closing of its ...

Investing.com -- PolyPeptide Group AG on Monday reported revenue of €389 million for the financial year 2025, representing a growth rate of 15.6% compared to the previous year.

ZURICH/FRANKFURT, Nov 11 (Reuters) - Family-owned contract manufacturer PolyPeptide is advancing preparations for a 2021 Zurich stock market listing or potential sale, two people close to the matter ...

PolyPeptide Group, controlled by a foundation of Swedish billionaire adventurer Frederik Paulsen Jr., said Monday it plans to list a 40% stake on the Swiss stock exchange to finance the contract drug ...

Lupin Manufacturing Solutions (LMS), a subsidiary of global pharma major Lupin Limited (Lupin), announced a long-term strategic alliance with PolyPeptide Group AG (PolyPeptide), a specialized, global ...

This collaboration offers an integrated solution for customers seeking to outsource the development and manufacturing of microbial and mammalian-expressed peptide drugs, with scalable options that ...